USD 235.69
(0.97%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 46.44 Million USD | 0.0% |
2023 | 49.67 Million USD | 13.9% |
2022 | 43.6 Million USD | -15.15% |
2021 | 51.39 Million USD | 14.68% |
2020 | 44.81 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q4 | 46.44 Million USD | 0.0% |
2024 Q3 | 48.02 Million USD | 0.0% |
2024 Q1 | 47.49 Million USD | 0.0% |
2024 FY | 46.44 Million USD | -6.5% |
2024 Q2 | 47.85 Million USD | 0.0% |
2023 Q2 | 52.1 Million USD | 22.71% |
2023 Q3 | 50.22 Million USD | -3.61% |
2023 FY | 49.67 Million USD | 13.9% |
2023 Q1 | 42.46 Million USD | -2.63% |
2023 Q4 | 49.67 Million USD | -1.11% |
2022 Q2 | 47.63 Million USD | -2.14% |
2022 Q1 | 48.67 Million USD | -5.29% |
2022 FY | 43.6 Million USD | -15.15% |
2022 Q4 | 43.6 Million USD | -3.6% |
2022 Q3 | 45.23 Million USD | -5.02% |
2021 Q1 | 42.43 Million USD | -5.32% |
2021 FY | 51.39 Million USD | 14.68% |
2021 Q4 | 51.39 Million USD | 7.15% |
2021 Q2 | 46.18 Million USD | 8.85% |
2021 Q3 | 47.96 Million USD | 3.85% |
2020 Q4 | 44.81 Million USD | 125.4% |
2020 Q1 | 13.43 Million USD | 0.0% |
2020 FY | 44.81 Million USD | 0.0% |
2020 Q2 | 15.51 Million USD | 15.5% |
2020 Q3 | 19.88 Million USD | 28.12% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Phreesia, Inc. | 2.04 Million USD | -2166.52% |
Accuray Incorporated | 164.4 Million USD | 71.751% |
Align Technology, Inc. | 96.96 Million USD | 52.107% |
Elevance Health Inc. | 23.24 Billion USD | 99.8% |
AxoGen, Inc. | 46.6 Million USD | 0.348% |
Boston Scientific Corporation | 8.56 Billion USD | 99.458% |
CVS Health Corporation | 74.67 Billion USD | 99.938% |
Cardinal Health, Inc. | 4.58 Billion USD | 98.987% |
Centene Corporation | 17.69 Billion USD | 99.738% |
DaVita Inc. | 8.05 Billion USD | 99.423% |
HCA Healthcare, Inc. | 36.62 Billion USD | 99.873% |
Hologic, Inc. | 2.49 Billion USD | 98.14% |
Humana Inc. | 10.21 Billion USD | 99.545% |
IDEXX Laboratories, Inc. | 622.88 Million USD | 92.544% |
Laboratory Corporation of America Holdings | 4.05 Billion USD | 98.855% |
Masimo Corporation | 871.7 Million USD | 94.672% |
McKesson Corporation | 5.45 Billion USD | 99.148% |
Patterson Companies, Inc. | 328.91 Million USD | 85.88% |
Quest Diagnostics Incorporated | 4.41 Billion USD | 98.947% |
ResMed Inc. | 697.31 Million USD | 93.34% |
Henry Schein, Inc. | 1.93 Billion USD | 97.597% |
Teladoc Health, Inc. | 1.58 Billion USD | 97.064% |
Universal Health Services, Inc. | 4.71 Billion USD | 99.015% |
Baxter International Inc. | 11.06 Billion USD | 99.58% |
Becton, Dickinson and Company | 14.73 Billion USD | 99.685% |
Intuitive Surgical, Inc. | -82.1 Million USD | 156.566% |
Danaher Corporation | 17.66 Billion USD | 99.737% |
Stryker Corporation | 10.9 Billion USD | 99.574% |
Medtronic plc | 23.87 Billion USD | 99.805% |